Inventor · disambiguated record
Douglas C. Hooper
Also filed as: HOOPER DOUGLAS C · HOOPER DOUGLAS CRAIG
19 granted patents·15 pending applications·163 citations·filing 1995–2025
93Inventor score
Top patents by PatentIndex Score
34 records- 0194US10357509B2Methods and compositions for treating cancers using antisenseUNIV JEFFERSON·Filed 2018·Granted Jul 23, 2019·5 cites·17 claims
- 0291US12064446B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2021·Granted Aug 20, 2024·1 cites·11 claims
- 0390US10772904B2Methods and compositions for treating cancers using antisenseUNIV JEFFERSON·Filed 2019·Granted Sep 15, 2020·2 cites·22 claims
- 0488US6042832APolypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteinsUNIV JEFFERSON·Filed 1996·Granted Mar 28, 2000·87 cites·12 claims
- 0588US2025009781A1Methods and Compositions for Treating Cancers and Enhancing Therapeutic Immunity by Selectively Reducing Immunomodulatory M2 MonocytesUNIV JEFFERSON·Filed 2024·Application pending·0 cites
- 0687US11077133B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2019·Granted Aug 3, 2021·1 cites·23 claims
- 0786US10265339B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2018·Granted Apr 23, 2019·3 cites·24 claims
- 0885US10206942B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2016·Granted Feb 19, 2019·3 cites·24 claims
- 0985US2024100078A1Methods and compositions for treating cancers using antisenseUNIV JEFFERSON·Filed 2023·Application pending·0 cites
- 1079US10543226B2Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytesUNIV JEFFERSON·Filed 2018·Granted Jan 28, 2020·1 cites·39 claims
- 1175US11801259B2Methods and compositions for treating cancers using antisenseUNIV JEFFERSON·Filed 2020·Granted Oct 31, 2023·0 cites·9 claims
- 1272US6448070B1Polypeptides fused with alfalfa mosaic virus or ilarvirus capsidUNIV JEFFERSON·Filed 1997·Granted Sep 10, 2002·26 cites·48 claims
- 1371US7071319B2Recombinant antibodies, and compositions and methods for making and using the sameUNIV JEFFERSON·Filed 2002·Granted Jul 4, 2006·1 cites·16 claims
- 1468US12472199B2P-ethoxy nucleic acids for IGF-1R inhibitionBIO PATH HOLDINGS INC·Filed 2021·Granted Nov 18, 2025·0 cites·4 claims
- 1567US8282939B2Attenuated live triple G protein recombinant rabies virus vaccine for pre- and post-exposure prophylaxis of rabiesFABER MILOSZ·Filed 2010·Granted Oct 9, 2012·1 cites·9 claims
- 1666US2025276166A1Biodiffusion chamberLAURENZI BRENDAN·Filed 2025·Application pending·0 cites
- 1764US6890532B2Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methodsUNIV JEFFERSON·Filed 2001·Granted May 10, 2005·2 cites·3 claims
- 1859US2023190919A1Coronavirus vaccine compositions and methods of useUNIV JEFFERSON·Filed 2021·Application pending·0 cites
- 1958US2004013672A1Recombinant antibodies, and compositions and methods for making and using the sameUNIV JEFFERSON·Filed 2003·Application pending·0 cites
- 2057US2020038429A1P-ethoxy nucleic acids for igf-1r inhibitionBIO PATH HOLDINGS INC·Filed 2018·Application pending·0 cites
- 2156US2021052875A1Biodiffusion chamberLAURENZI BRENDAN·Filed 2019·Application pending·0 cites
- 2255US5935570ASynthesis of immunologic, therapeutic and prophylactic compounds by transformed clavibacterUNIV JEFFERSON·Filed 1995·Granted Aug 10, 1999·11 cites·18 claims
- 2352US6129921AViral ribonucleocapsid as an immunological enhancerUNIV JEFFERSON·Filed 1995·Granted Oct 10, 2000·14 cites·4 claims
- 2452US2006216300A1Recombinant antibodies and compositions and methods for making and using the sameUNIV JEFFERSON·Filed 2004·Application pending·0 cites
- 2551US2022000916A1Methods and compositions for treating breast cancer using antisenseUNIV JEFFERSON·Filed 2019·Application pending·0 cites
- 2651US2021403918A1Methods and compositions for treating hepatocellular carcinoma using antisenseUNIV JEFFERSON·Filed 2019·Application pending·0 cites
- 2751US2022195440A1Methods for treating cancers using antisenseUNIV JEFFERSON·Filed 2020·Application pending·0 cites
- 2848US2021389329A1Compositions and Methods for Discriminating Infectious from Non-Infectious CNS DisordersUNIV JEFFERSON·Filed 2019·Application pending·0 cites
- 2945US2022040279A1Neoantigen compositions; and methods of preparation and use thereofUNIV JEFFERSON·Filed 2019·Application pending·0 cites
- 3044US9889192B2Immunization with rabies virus vector expressing foreign protein antigenUNIV JEFFERSON·Filed 2013·Granted Feb 13, 2018·0 cites·20 claims
- 3143US2020054761A1Methods and composition for inhibiting tumor growth and enhancing immune responses to tumorsUNIV JEFFERSON·Filed 2018·Application pending·0 cites
- 3239US2022370773A1Apparatus and methods for biodiffusion chamber storageUNIV JEFFERSON·Filed 2020·Application pending·0 cites
- 3335US5872124ATreatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitriteUNIV JEFFERSON·Filed 1996·Granted Feb 16, 1999·5 cites·5 claims
- 3423USD1107915SBiodiffusion chamberUNIV JEFFERSON·Filed 2019·Granted Dec 30, 2025·0 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →